WEC
QTTB icon

Winslow Evans & Crocker’s Q32 Bio QTTB Stock Holding History

Winslow Evans & Crocker’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$2K Buy
+11
New +$2.13K ﹤0.01% 1254

Other funds holding QTTB

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Winslow Evans & Crocker's QTTB Position: Q4 2020 in Review

Winslow Evans & Crocker opened a new position in Q32 Bio (QTTB) in Q4 2020: 11 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #1254 among its holdings.

106 funds tracked by Wall St. Rank hold QTTB as of Q4 2020.

  • Winslow Evans & Crocker held 11 shares of Q32 Bio worth $2K as of Q4 2020.
  • Q32 Bio was a new Winslow Evans & Crocker position in Q4 2020.
  • Q32 Bio made up ﹤0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #1254 holding.
  • 106 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.